• Crestor
• Banned
• Cardiomyopathy
• Cases
• Cholesterol
• Class Action
• Concerns
• Dangers
• Deaths
• Diabetes
• Heart Failure
• Heart Failure Lawsuit
• Heart Failure Lawyer
• Heart Problems
• Kidney Failure
• Kidney Pain
• Lawsuit
• Leg Pain
• Liver Damage
• Liver Failure
• Medication
• Muscle Damage
• Muscle Pain
• News
• Patient Information
• Problem
• Recall
• Renal Failure
• Rhabdomyolysis
• Risk
• Safety
• Side Effects
• Statin Drug
• Warning
• Weight Loss
• Contact a Lawyer

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

If a person takes Crestor and kidney pain is experienced, the patient may be suffering from the more serious side effects caused by this drug. Crestor is a statin prescription drug used to treat patients with high cholesterol. AstraZeneca, the manufacturer of Crestor, has employed aggressive marketing strategies to push this prescription drug. Eleven million Crestor prescriptions have been distributed worldwide and revenues for this drug total in the billions of dollars.

Crestor was approved by the Federal Drug Administration in August of 2003 for use in patients with high cholesterol. AstraZeneca filed for approval in 2001 but approval was delayed when harmful side effects, such as Crestor and kidney pain, were found in patients taking higher doses of Crestor. In light of this evidence the FDA approved this drug in five, ten, and twenty milligram doses, with restricted dosing in the 40 milligram strength. Crestor was not approved in the 80 milligram strength.

Crestor Drug Recall

Consumer advocate groups have been battling to have Crestor recalled since it was approved for use in the United States. Crestor and kidney pain is sited as one of the serious risks associated with taking this medication. The manufacture of Crestor claims that Crestor is no more dangerous than other statin drugs used in treating high cholesterol. This claim follows the recall of a similar statin drug in 2001. Baycol, once produced by Bayer, was recalled because of serious side effects associated with its use.

Crestor & Rhabdomyolysis

Crestor and kidney pain is an indication of a serious degenerative muscle disease called Rhabdomyolosis. Rhabdomyolosis causes the breakdown of muscle cells throughout the body. This breakdown in turn causes the release of muscle fiber contents into the bloodstream. This release leads to a reduction in the amount of blood circulating in the body. These chemicals are highly toxic in the kidneys, which is why Crestor and kidney pain are linked. Rhabdomyolosis, caused by Crestor and kidney pain, can lead to acute renal failure or damage to other internal organs.

If you take Crestor and kidney pain is a side effect you have experienced, it is important to seek medical attention as soon as possible. Crestor and kidney pain can lead to serious and potentially deadly health conditions. The manufacturers of this product have failed to take any measures that would protect patients from Crestor and kidney pain. The FDA has made no indication that they plan to recall this medication, despite numerous reports of Crestor and kidney pain, stating that they will only take steps to monitor safety reports regarding Crestor and kidney pain.

If you have been injured as a result of Crestor and kidney pain, you may wish to speak to a qualified legal professional to determine your eligibility for a Crestor and kidney pain law suit to recover the damages you have suffered.

"Possible Crestor®-Heart Failure Link"

Some researchers believe the cholesterol medication Crestor® (rosuvastatin) can increase the severity of heart failure in certain patients.

Coenzyme Q10 (CoQ10), pro...

» Read More

"FDA rejects petition to ban Crestor"

The consumer advocacy group Public Citizen submitted a petition to the FDA a year ago asking the agency to immediately withdraw the anti-cholesterol drug Crestor, but the agency has denied its request.

Crestor belongs to a group of drugs ...

» Read More

"Asians taking Crestor may be at higher risk for rhabdomyolysis"

The FDA has announced that Crestor is being relabeled to add a warning that starter doses should be reduced in Asian-American patients, as well as some other higher risk patients.

A clinical trial found that levels in Asian patients were d...

» Read More